Clinical Trial Update: A Phase III Study of Human Papillomavirus (HPV)-16/18 Vaccine. [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial of an HPV-16/18 vaccine completed, investigating protection against HPV infections types 16 and 18 and cervical intraepithelial neoplas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Intraepithelial Neoplasia
• Human Papillomavirus Infection Type 16
• Human Papillomavirus Infection Type 18

Drugs mentioned

• HPV-16/18 vaccine (Cervarix)

Snippet

Sponsor: Shanghai Zerun Biotechnology Co.,Ltd | Conditions: Human Papilloma Virus Infection Type 16, Human Papilloma Virus Infection Type 18 | Phase 3 | Status: COMPLETED